SEZGİN, G. Et Al. 2014. Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11 , 4549-4553.

SEZGİN, G., ACIPAYAM, C., ÖZKAN, A., Bayram, I., & TANYELİ, A., (2014). Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11, 4549-4553.

SEZGİN, GÜLAY Et Al. "Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11, 4549-4553, 2014

SEZGİN, GÜLAY Et Al. "Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11, pp.4549-4553, 2014

SEZGİN, G. Et Al. (2014) . "Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11, pp.4549-4553.

@article{article, author={GÜLAY SEZGİN Et Al. }, title={Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2014, pages={4549-4553} }